Source:http://linkedlifedata.com/resource/pubmed/id/19364364
General Info
Affiliation
Dipartimento di Neuroscienze, Università Tor Vergata, Rome, Italy.Abstract
Central neuropathic pain (CNP) is a prevalent and distressing symptom in patients with multiple sclerosis (MS). The anticonvulsant levetiracetam (LEV) has been shown to be efficacious in some types of CNP, but its efficacy in MS-related CNP has not been confirmed.
PMID
19364364
Publication types
Randomized Controlled Trial; Research Support, Non-U.S. Gov't